147 related articles for article (PubMed ID: 17409273)
1. Chronic treatment with carvedilol improves Ca(2+)-dependent ATP consumption in triton X-skinned fiber preparations of human myocardium.
Brixius K; Lu R; Boelck B; Grafweg S; Hoyer F; Pott C; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2007 Jul; 322(1):222-7. PubMed ID: 17409273
[TBL] [Abstract][Full Text] [Related]
2. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
Lee S; Lu R; Müller-Ehmsen J; Schwinger RH; Brixius K
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol, carvedilol and metoprolol do not influence cardiac Ca(2+) sensitivity.
Bundkirchen A; Brixius K; Bölck B; Mehlhorn U; Bloch W; Schwinger RH
Eur J Pharmacol; 2001 Jun; 422(1-3):175-80. PubMed ID: 11430928
[TBL] [Abstract][Full Text] [Related]
4. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
5. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
6. Different intrinsic activities of bucindolol, carvedilol and metoprolol in human failing myocardium.
Maack C; Cremers B; Flesch M; Höper A; Südkamp M; Böhm M
Br J Pharmacol; 2000 Jul; 130(5):1131-9. PubMed ID: 10882399
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Molenaar P; Christ T; Ravens U; Kaumann A
Cardiovasc Res; 2006 Jan; 69(1):128-39. PubMed ID: 16225854
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
10. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
Jacob S; Rett K; Wicklmayr M; Agrawal B; Augustin HJ; Dietze GJ
J Hypertens; 1996 Apr; 14(4):489-94. PubMed ID: 8761899
[TBL] [Abstract][Full Text] [Related]
13. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium.
Brixius K; Mehlhorn U; Bloch W; Schwinger RH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466
[TBL] [Abstract][Full Text] [Related]
14. Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.
Brixius K; Savidou-Zaroti P; Bloch W; Schwinger RH
Eur J Appl Physiol; 2003 May; 89(3-4):249-56. PubMed ID: 12736832
[TBL] [Abstract][Full Text] [Related]
15. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
Sanderson JE; Leung LY; Chan SK; Yip GW; Fung JW; Yu CM
Eur J Heart Fail; 2005 Aug; 7(5):874-7. PubMed ID: 16043407
[TBL] [Abstract][Full Text] [Related]
16. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Brixius K; Bundkirchen A; Bölck B; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2001 Aug; 133(8):1330-8. PubMed ID: 11498519
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
Vittorio TJ; Zolty R; Kasper ME; Khandwalla RM; Hirsh DS; Tseng CH; Jorde UP; Ahuja K
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):51-7. PubMed ID: 18287590
[TBL] [Abstract][Full Text] [Related]
19. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
Sun YL; Hu SJ; Wang LH; Hu Y; Zhou JY
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
